Results 111 to 120 of about 22,962 (264)

Virtual Affinity Fingerprints for Target Fishing: A New Application of Drug Profile Matching [PDF]

open access: yes, 2013
We recently introduced Drug Profile Matching (DPM), a novel virtual affinity fingerprinting bioactivity prediction method. DPM is based on the docking profiles of ca.
Czobor, P.   +6 more
core   +1 more source

Hippocampus and basal forebrain volumes modulate effects of anticholinergic treatment on delayed recall in healthy older adults

open access: yesAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2015
Introduction Volumes of hippocampus and cholinergic basal forebrain are associated with delayed recall performance and may modulate the effect of a muscarinic receptor antagonist on delayed recall in healthy volunteers. Methods We studied 15 older adults
Stefan J. Teipel   +4 more
doaj   +1 more source

Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor [PDF]

open access: yes, 2014
Background: Selective and potent positive allosteric modulators (PAMs) of the M1 mAChR have been recently described. Results: Use of structural analogues and mutagenic mapping identified the mechanistic basis for increased PAM activity.
Abdul-Ridha   +42 more
core   +2 more sources

Increased Leptin/Leptin Receptor Pathway Affects Systemic and Airway Inflammation in COPD Former Smokers [Retraction]

open access: yesJournal of Inflammation Research, 2021
Bruno A, Alessi M, Soresi S, et al. J Inflamm Res. 2011;4:51–59. The Editor and Publisher of Journal of Inflammation Research wish to retract the published article.
Bruno A   +8 more
doaj  

Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease. [PDF]

open access: yesProc Natl Acad Sci U S A, 2021
Scarpa M   +14 more
europepmc   +1 more source

The M1 muscarinic receptor is present in situ as a ligand-regulated mixture of monomers and oligomeric complexes. [PDF]

open access: yesProc Natl Acad Sci U S A, 2022
Marsango S   +10 more
europepmc   +1 more source

M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease. [PDF]

open access: yesSci Signal, 2022
Dwomoh L   +13 more
europepmc   +1 more source

D₂ Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways [PDF]

open access: yes, 2005
Regulator of G-protein signaling 9-2 (RGS9-2), a member of the RGS family of Gα GTPase accelerating proteins, is expressed specifically in the striatum, which participates in antipsychotic-induced tardive dyskinesia and in levodopa-induced dyskinesia. We
Axelrod, Jeffrey D.   +10 more
core  

M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways [PDF]

open access: bronze, 2000
Corinne Leloup   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy